Genotoxic effects of estrogens in epithelial cells from the neonatal mouse uterine cervix: Modifications by metabolic modifiers
- 1 January 1989
- journal article
- research article
- Published by Wiley in Teratogenesis, Carcinogenesis, and Mutagenesis
- Vol. 9 (2) , 97-110
- https://doi.org/10.1002/tcm.1770090205
Abstract
Epithelium from the neonatal mouse uterine cervix and uppermost part of vagina was cultured in vitro. The culture medium was supplemented with 17β‐estradiol (E2; 10–6–10–5 M) or diethylstilbestrol (DES; 10–8–10–5 M) alone or in combination with different metabolic modifiers (α‐naphthoflavone, β‐naphthoflavone, phenobarbital, metyrapone, indomethacin) with postulated activating or inhibitory effects on DES metabolizing enzymes (cytochrome P‐448‐ and P‐450‐dependent microsomal monooxidases, prostaglandin cyclooxygenase). E2 at 10–5 M and DES at 10–6 and 10–5 M concentrations increased the incidence of cells with a high number of sister chromatid exchanges (high‐frequency chromatid exchange cells, HFCEC). Indomethacin partially depressed DES‐induced HFCEC, whereas the incidence was increased by α‐naphthoflavone, which may be a result of stimulation of the fetal type of P‐448‐dependent enzyme activity or of DES increasing the metabolic activation of α‐naphthoflavone. Phenobarbital and β‐naphthoflavone did not affect the incidence of DES‐induced HFCEC. Metyrapone alone induced the highest incidence of HFCEC observed in this study, and this effect was inactivated by phenobarbital and/or DES. The mechanisms behind these results are discussed. This study shows that E2 and DES have a genotoxic effect (sister chromatid exchanges) in vitro in epithelial cells from the same target organ as in which epithelial aberrations occur after in vivo estrogen treatment in the neonatal period. The difference in incidence of tetraploid cells between stroma and epithelium is stressed (< 5% vs. 16–47% depending on experimental group).Keywords
This publication has 46 references indexed in Scilit:
- Induction of estrogen receptor, peroxidase activity, and epithelial abnormalities in the mouse uterovaginal epithelium after neonatal treatment with diethylstilbestrolTeratogenesis, Carcinogenesis, and Mutagenesis, 1988
- A monoclonal antibody against cytochrome P-450 enhances mutagen activation of N-nitrosodimethylamine by mouse liver S9: studies on the mode of actionCarcinogenesis: Integrative Cancer Research, 1987
- 17β-Estradiol-induced cell transformation and aneuploidy of Syrian hamster embryo cells in cultureCarcinogenesis: Integrative Cancer Research, 1987
- Reduction of irreversible binding of diethylstilbestrol in hamster renal cortex by inhibitors of cytochrome P-450Toxicology and Applied Pharmacology, 1987
- Inhibition of the prenatal dimethylbenz[a]anthracene-induced tumour initiation in mice by prior administration of 7, 8-benzoflavoneCarcinogenesis: Integrative Cancer Research, 1986
- Indomethacin Metabolism in Liver Microsomes during Postnatal Development in the RatNeonatology, 1986
- Nature of the macromolecular binding of diethylstilbestrol to DNA and protein following oxidation by peroxidase/hydrogen peroxideChemico-Biological Interactions, 1985
- Dearylation and other cleavage reactions of diethylstilbestrol: novel oxidative pathways mediated by peroxidasesXenobiotica, 1985
- Inhibition of oxidative drug metabolism in microsomesPharmacology & Therapeutics, 1980
- Metabolites of diethylstilboestrol induce sister chromatid exchange in human cultured fibroblastsNature, 1979